NASDAQ-GS · traded in Congress
Legence LGN
$27.91 +2.50 (+9.84%) Nov 6, 2026
Market value$3.0B
P/E ratio-
Analyst target$100.00
52-week range-
Avg volume1,163,956
Dividend yieldN/A
Chart
Earnings
Legence reports Thursday, November 12, before the open.
Analyst ratings
- 16 buy
- 1 hold
- 0 sell
Low target$60.00
Average target$94.35
High target$130.00
Quarterly financials
| Quarter ended | Revenue | Gross profit | Net income | Net margin |
|---|---|---|---|---|
| $1,262M | $220M | $-28M | -2.2% | |
| $1,038M | $186M | $16M | 1.6% | |
| $738M | $147M | $-33M | -4.4% | |
| $708M | $148M | $-1M | -0.1% |
Congress trades in LGN
Members of Congress disclosed 1 transaction in LGN in the filings we have processed.
| Traded | Member | Type | Amount | Filed |
|---|---|---|---|---|
| 03/03/2026 | Gilbert Cisneros CA31 | Purchase | $1,001 - $15,000 | 4/7/2026 filing |
Disclosed under the STOCK Act. Amounts are the ranges the law requires, filings can lag a trade by up to 45 days, and a disclosure is not evidence of wrongdoing. All congressional trades ›
Other companies
Price and key figures from Nasdaq's public quote data, refreshed through the day; the chart is live from TradingView; options activity, ratings, financials, earnings and filings refreshed through the day. Congressional trades parsed from official House filings. Market information, not investment advice.
